USA

News

University Hospitals System Widens Use of Magseed Marker

Tuesday, 13 March, 2018

Endomag announced today that University Hospitals (UH), one of the leading healthcare systems in the US, providing high-quality, patient-centred cancer care at locations throughout Northeast Ohio, has expanded the use of its Magseed® marker technology at more sites within the UH system. Magseed...

World First for Magseed

Thursday, 22 February, 2018

Endomag announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to extend the indication of its Magseed® magnetic marker to include both the marking of soft tissue and long-term implantation. The Magseed marker has already been used in thousands of...

Endomag receives CE Mark for Magseed

Wednesday, 13 September, 2017

Endomag announced today that it has received CE Mark approval for Magseed®, a minimally invasive breast marker used to accurately guide surgeons during breast cancer removal. Magseed will be distributed throughout EMEA by Sysmex, as part of a new 5-year distribution deal for the Sentimag®...

Ochsner

Ochsner Health System adopts Magseed

Monday, 8 May, 2017

Endomag announced today that Ochsner Health System has adopted Magseed® as the standard of care for breast lesion localisation, having identified the system as simpler and more effective than alternative techniques. Magseed was chosen as the preferred alternative to wire localisation, based on...

Peter Keen

Endomag Strengthens Board with Key Appointment

Monday, 3 April, 2017

Endomag announced today the appointment of Peter Keen as non-executive director, effective immediately.
 
Since the launch of Magseed®, Endomag’s breast lesion localisation device, in November 2016, interest has exceed expectations. Over 150 hospitals, including 30 of the top 50...

Endomag

Please select if you are based outside the U.S.A.

Choose

Endomag US

Please select if you are based in the U.S.A.

Choose